NCT02072200View on ClinicalTrials.gov

Efficacy of Lodotra®(Prednisone) in Reduction of Morning Stiffness Duration(K-IMPROvE)

PHASE4CompletedINTERVENTIONAL
Enrollment

147

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Lodotra®

Single arm will be received below oral 10mg tablet daily and maximum 10mg/d depending on the clinical symptoms and the patient's response

Trial Locations (1)

Unknown

Hallym University Sacred Heart Hospital, Pyeongchon

All Listed Sponsors
lead

Mundipharma Korea Ltd

INDUSTRY

NCT02072200 - Efficacy of Lodotra®(Prednisone) in Reduction of Morning Stiffness Duration(K-IMPROvE) | Biotech Hunter | Biotech Hunter